missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human PRAS40 Synthetic Peptide
Synthetic Peptide
Brand: Invitrogen™ PEP1608
This item is not returnable.
View return policy
Description
AKT1S1 Synthetic Peptide, PEP-1608, from Invitrogen.
The Akt signaling pathway contributes to the regulation of apoptosis after a variety of cell death signals. AKT1S1, also known as PRAS40, is a proline-rich substrate of the kinase AKT1 and is thought to play a role in neuroprotection mediated by nerve growth factor (NGF) after transient focal cerebral ischemia. AKT1S1 is also a substrate and potential regulator of mammalian target of rapamycin (mTOR), a serine/threonine kinase that regulates cell growth and cell cycle, and a negative regulator of autophagy. Treatment with the insulin-like growth factor-1 (IGF1) can induce the phosphorylation of AKT1S1 via the PI3K/AKT signaling pathway in PC12 cells.
Specifications
| 84335 | |
| purified | |
| Human PRAS40 | |
| -20°C | |
| Liquid | |
| Blocking Assay, Control | |
| No | |
| Peptide | |
| RUO - research use only |
| Human | |
| Q96B36 | |
| 200 μg/mL | |
| Synthetic Peptide | |
| PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2 | |
| AKT1S1 | |
| 0.02% sodium azide | |
| 50 μg | |
| PBS |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Invitrogen™ Human PRAS40 Synthetic Peptide > 50 μg; Unlabeled
Spot an opportunity for improvement?Share a Content Correction
